PMI

Picard Medical, Inc. PMI

NYSESmall CapHealthcare

13F Pro quality score

Rank #2,366 of 2,925

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$2.95M

Quarter to Jun 30

Net income

$-5.66M

Quarter to Jun 30

Free cash flow

$-1.35M

Quarter to Jun 30

Operating margin

-156.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$1.24M total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PMI

Loading ratio trend…

PMI key financials by period

Reported revenue, net income and operating margin by fiscal year, from Picard Medical, Inc.'s annual filings on SEC EDGAR.

Picard Medical, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$4.9M$-27.0M—
FY 2024$4.4M$-21.1M—
Source: PMI filings on SEC EDGAR →

About Picard Medical, Inc. (PMI): stock profile, AI score and financials

Picard Medical, Inc. (PMI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PMI at 33.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,366 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Picard Medical, Inc. reports quarterly revenue of $3.0M, net income of $-5.7M, an operating margin of -156.7%. Top institutional holders of PMI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, AQR CAPITAL MANAGEMENT, JANE STREET GROUP, based on the most recent SEC filings. PMI trades on the NYSE exchange and files with the SEC under CIK 2030617. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PMI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Picard Medical, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2030617 →